Future research should not only clarify the cell-type-specific functions of SIRT7 but also determine whether its modulation can be exploited to fine-tune the interplay between tumor-intrinsic programs and anti-cancer immunity, ultimately guiding the design of next-generation therapeutic strategies. The gene discussed is SIRT7; the disease is neoplasm.